w.moreau
TL2 Moderator · Mombasa
Contributes reviews on supplier material. Based in Mombasa.
Joined 2 August 2025 · last posted 5d
75Posts here
4Topics
0Solutions
1.8kLikes received
1.9kLikes given
23Badges
217Days visited
4.6kPosts read
Recent activity
Full stream-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #68 · Practice › Side effects · 22 Jul 2026 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Restarting after a long gap: what the labelling implies Replied, post #27 · Practice › Dosing & titration · 15 Jul 2026 · 0 likes post #26 is right about the mechanism and I think understates the practical bit. Dose equivalence between different incretin analogues is a weak concept. The molecules…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #108 · Evidence › Journal club · 15 Jul 2026 · 12 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Review: an evidence digest and the citation check that delayed it Replied, post #16 · Documentation › Doc review · 15 Jul 2026 · 1 like Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #28 · Access › Insurance & coverage · 14 Jul 2026 · 3 likes Worth separating two things that post #24 runs together. Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but…
-
Insurance and replacement policies, compared Replied, post #88 · Sourcing › Logistics · 14 Jul 2026 · 11 likes On post #84 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #61 · Access › International · 6 Jul 2026 · 0 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #39 · Research Methods › Statistics · 5 Jul 2026 · 0 likes Confidence intervals: rather than a single point estimate, a range of plausible values. A narrow interval means precise measurement; a wide interval means measurement…
-
Restarting after a long gap: what the labelling implies Replied, post #10 · Practice › Dosing & titration · 3 Jul 2026 · 15 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #15 · Analytics › Home & field testing · 3 Jul 2026 · 21 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
-
Follow-up: Reading an interaction checker output critically Replied, post #20 · Practice › Interactions · 26 Jun 2026 · 2 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #5 · Nutrition & Training › Protein & intake · 24 Jun 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Meeting protein targets on suppressed appetite: this is where the practical difficulty lies.…